Painchek has one of the most comprehensive quarterlies out of asx small caps. They provide qualitative and quantitative updates on everything in their pipeline.
Coupled with decent social media presence, it would be a complete waste of resources to constantly provide more, simply to satisfy the whims of inpatient holders. Corporate comms don’t write themselves.
PCK Price at posting:
2.7¢ Sentiment: Buy Disclosure: Held
